| 别名 |
(S)-2-(2-Oxopyrrolidin-1-yl)butanamide;(S)-1-pyrrolidineacetamid;2-(2-oxopyrrolidin-1-yl)butanamide;(+-)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide;(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide;1-Pyrrolidineacetamide;alpha-ethyl-2-oxo-;alpha-Ethyl-2-oxo-1-pyrrolidineacetamide;Etiracetam;Etiracetam [INN];Etiracetamum [INN-Latin];Keppra;Levetiracetam [INN];Levetiracetamum [INN-Latin];LEVITIRACETAM;UCB 6474;UCB-6474;UCB-L 059;Name:(S)-2-(2-Oxopyrrolidin-1-yl)butanamide (Levetiracetam);Levetiracetam;Levetiracetam solution;Levetirazetam;UCB L059;(2S)-2-(2-oxopyrrolidin-1-yl)butanamide;(S)-2-(2-Oxo-1-pyrrolidinyl)butyramide;Levetiracetin;(αS)-α-Ethyl-2-oxo-1-pyrrolidineacetamide;2(S)-(2-oxopyrrolidin-1-yl)butyramide;Keppra®;SIB-S1;MFCD00;Levetiractam;Levetiracetame;UCB-L059;103833-73-4;Keppra XR;Levetiracetamum;Spritam;(-)-(S)-alpha-Ethyl-2-oxo-1-pyrrolidineacetamide;1-Pyrrolidineacetamide, alpha-ethyl-2-oxo-, (alphaS)-;ucb L060;Levetiracetam In Sodium Chloride;44YRR34555;Levroxa;1-Pyrrolidineacetam |